|
Device | Eluvia Drug-Eluting Vascular Stent System |
Generic Name | Stent, superficial femoral artery, drug-eluting |
Applicant | Boston Scientific Corp. One Scimed Place Maple Grove, MN 55311 |
PMA Number | P180011 |
Date Received | 04/13/2018 |
Decision Date | 09/18/2018 |
Product Code |
NIU |
Docket Number | 18M-3548 |
Notice Date | 09/20/2018 |
Advisory Committee |
Cardiovascular |
Clinical Trials | NCT02574481
|
Expedited Review Granted? | No |
Combination Product | Yes |
Approval Order Statement Approval for the ELUVIA Drug-Eluting Vascular Stent System. The device is indicated for improving luminal diameter in the treatment of symptomatic de-novo or restenotic lesions in the native superficial femoral artery (SFA) and/or proximal popliteal artery with reference vessel diameters (RVD) ranging from 4.0 - 6.0 mm and total lesion lengths up to 190 mm. |
Approval Order | Approval Order |
Summary | Summary of Safety and Effectiveness |
Labeling | Labeling Labeling Part 2 |
Post-Approval Study | Show Report Schedule and Study Progress |
Supplements: |
S043 S051 S038 S039 S040 S048 S056 S052 S044 S045 S046 S047 S041 S050 S049 S007 S008 S036 S037 S022 S023 S024 S025 S026 S027 S030 S031 S014 S015 S016 S001 S002 S003 S017 S018 S019 S020 S021 S010 S011 S012 S013 S034 S035 S042 S053 S054 S028 S029 S032 S033 S009 S004 S005 |